Global clinical trials market will reach $79,977.1 million by 2031, growing by 7.0% annually over 2022-2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments.
Highlighted with 148 tables and 111 figures, this 241-page report "Global Clinical Trials Market 2022-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Region: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire global clinical trials market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2022 and provides forecast from 2023 till 2031 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global clinical trials market in every aspect of the classification from perspectives of Product Category, Phase, Design, Service Type, Indication, End User, and Region.
Based on Product Category, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Trials of Drugs
o Small Molecule Drugs
o Vaccines
o Cell & Gene Therapy
o Other Drugs
• Trials of Devices
• Trials of Procedures
Based on Phase, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Phase I
• Phase II
• Phase III
• Phase IV
By Design, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Interventional Studies
o Randomized Control Trial
o Adaptive Clinical Trial
o Non-randomized Control Trial
• Observational Studies
o Cohort Study
o Case Control Study
o Cross Sectional Study
o Ecological Study
• Expanded Access Trials
By Service Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Protocol Designing
• Site Identification
• Patient Recruitment
• Laboratory Services
• Bioanalytical Testing Services
• Clinical Trial Data Management Services
• Clinical Trial Supply & Logistic Services
• Decentralized Clinical Trial Services
• Medical Device Testing Services
• Other Clinical Trial Services
By Indication, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Oncology
• Infectious Diseases
• Cardiology
• Obesity
• Diabetes
• Neurology
• Immunology
• Pain Management
• Other Indications
By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Pharmaceutical and Biotechnological Companies
• Clinical Research Organizations
• Clinical Testing Laboratories
• Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa and Rest of MEA)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2031. The breakdown of all regional markets by country and split of each national market by Phase, Design, and Indication over the forecast years are also included.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Accell Clinical Research LLC
Charles River Laboratories
ClinDatrix Inc
Clinipace
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
ICON PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America (Covance Inc.)
Novo Nordisk AS
PAREXEL International Corporation
Pfizer Inc.
Pharmaceutical Product Development LLC
Phlexglobal
PRA Health Sciences
Sanofi SA
SGS SA (SGS Life Sciences)
Syneos Health Inc.
Wuxi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 12
1.1 Industry Definition and Research Scope 12
1.1.1 Industry Definition 12
1.1.2 Research Scope 13
1.2 Research Methodology 16
1.2.1 Overview of Market Research Methodology 16
1.2.2 Market Assumption 17
1.2.3 Secondary Data 17
1.2.4 Primary Data 17
1.2.5 Data Filtration and Model Design 18
1.2.6 Market Size/Share Estimation 19
1.2.7 Research Limitations 20
1.3 Executive Summary 21
2 Market Overview and Dynamics 24
2.1 Market Size and Forecast 24
2.1.1 Impact of COVID-19 on World Economy 26
2.1.2 Impact of COVID-19 on the Market 29
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 31
2.2 Major Growth Drivers 35
2.3 Market Restraints and Challenges 42
2.4 Emerging Opportunities and Market Trends 45
2.5 Porter's Fiver Forces Analysis 49
3 Segmentation of Global Market by Product Category 53
3.1 Market Overview by Product Category 53
3.2 Trials of Drugs 55
3.2.1 Small Molecule Drugs 56
3.2.2 Vaccines 57
3.2.3 Cell & Gene Therapy 58
3.2.4 Other Drugs 59
3.3 Trials of Devices 60
3.4 Trials of Procedures 61
4 Segmentation of Global Market by Phase 62
4.1 Market Overview by Phase 62
4.2 Phase I 64
4.3 Phase II 65
4.4 Phase III 66
4.5 Phase IV 67
5 Segmentation of Global Market by Design 68
5.1 Market Overview by Design 68
5.2 Interventional Studies 70
5.2.1 Randomized Control Trial 72
5.2.2 Adaptive Clinical Trial 73
5.2.3 Non-randomized Control Trial 74
5.3 Observational Studies 75
5.3.1 Cohort Study 77
5.3.2 Case Control Study 78
5.3.3 Cross Sectional Study 79
5.3.4 Ecological Study 80
5.4 Expanded Access Trials 81
6 Segmentation of Global Market by Service Type 82
6.1 Market Overview by Service Type 82
6.2 Protocol Designing 84
6.3 Site Identification 85
6.4 Patient Recruitment 86
6.5 Laboratory Services 87
6.6 Bioanalytical Testing Services 88
6.7 Clinical Trial Data Management Services 89
6.8 Clinical Trial Supply & Logistic Services 90
6.9 Decentralized Clinical Trial Services 91
6.10 Medical Device Testing Services 92
6.11 Other Clinical Trial Services 93
7 Segmentation of Global Market by Indication 94
7.1 Market Overview by Indication 94
7.2 Oncology 96
7.3 Infectious Diseases 97
7.4 Cardiology 98
7.5 Obesity 99
7.6 Diabetes 100
7.7 Neurology 101
7.8 Immunology 102
7.9 Pain Management 103
7.10 Other Indications 104
8 Segmentation of Global Market by End User 105
8.1 Market Overview by End User 105
8.2 Pharmaceutical and Biotechnological Companies 107
8.3 Clinical Research Organizations 108
8.4 Clinical Testing Laboratories 109
8.5 Other End Users 110
9 Segmentation of Global Market by Region 111
9.1 Geographic Market Overview 2021-2031 111
9.2 North America Market 2021-2031 by Country 115
9.2.1 Overview of North America Market 115
9.2.2 U.S. 119
9.2.3 Canada 122
9.2.4 Mexico 124
9.3 European Market 2021-2031 by Country 126
9.3.1 Overview of European Market 126
9.3.2 Germany 130
9.3.3 U.K. 132
9.3.4 France 134
9.3.5 Spain 136
9.3.6 Italy 138
9.3.7 Russia 140
9.3.8 Rest of European Market 142
9.4 Asia-Pacific Market 2021-2031 by Country 144
9.4.1 Overview of Asia-Pacific Market 144
9.4.2 Japan 148
9.4.3 China 151
9.4.4 Australia 153
9.4.5 India 155
9.4.6 South Korea 157
9.4.7 Rest of APAC Region 159
9.5 South America Market 2021-2031 by Country 161
9.5.1 Argentina 164
9.5.2 Brazil 166
9.5.3 Chile 168
9.5.4 Rest of South America Market 170
9.6 MEA Market 2021-2031 by Country 171
9.6.1 UAE 174
9.6.2 Saudi Arabia 176
9.6.3 South Africa 178
9.6.4 Other National Markets 180
10 Competitive Landscape 181
10.1 Overview of Key Vendors 181
10.2 New Product Launch, Partnership, Investment, and M&A 185
10.3 Company Profiles 186
Accell Clinical Research LLC 186
Charles River Laboratories 188
ClinDatrix Inc 191
Clinipace 192
Eli Lilly and Company 194
F. Hoffmann-La Roche Ltd. 197
ICON PLC 200
IQVIA Holdings, Inc. 203
Laboratory Corporation of America (Covance Inc.) 207
Novo Nordisk AS 211
PAREXEL International Corporation 214
Pfizer Inc. 218
Pharmaceutical Product Development LLC 223
Phlexglobal 226
PRA Health Sciences 228
Sanofi SA 230
SGS SA (SGS Life Sciences) 233
Syneos Health Inc. 236
Wuxi AppTec Inc. 239
RELATED REPORTS 241
The Digital Pathology Image Analysis Software for Clinical Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, com...
The Decentralized & Digitalized Clinical Trials Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive la...
The Clinical Trial Temperature Control Logistics Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive l...
The Clinical Trial Drug Sourcing Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsca...
The Clinical Trial Logistics Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
The Clinical Trial Adjudication Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape,...
The Clinical Trial Simulation Tools Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...
The Cloud Computing in Clinical Trials Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...
The Clinical Database Management Systems Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...
The Clinical Trial Management Organizations Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...